Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt

Ulrich Rohde; Silas Gylvin; Peter Vilmann; Steffen Ulrik Friis; Ebbe Langholz; Tina Vilsbøll; Filip Krag Knop

Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt

Ulrich Rohde, Silas Gylvin, Peter Vilmann, Steffen Ulrik Friis, Ebbe Langholz, Tina Vilsbøll, Filip Krag Knop

Abstract

Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.

Bidragets oversatte titel	Duodenal-jejunal bypass sleeve - a potential alternative to bariatric surgery?
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	176
Udgave nummer	37
Sider (fra-til)	1874-1877
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 29 sep. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

@article{049cd24c4bc946ca8d76d738ac7701b9,

title = "Behandling med duodenal-jejunal bypass-sleeve ved sv{\ae}r overv{\ae}gt",

abstract = "Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.",

author = "Ulrich Rohde and Silas Gylvin and Peter Vilmann and Friis, {Steffen Ulrik} and Ebbe Langholz and Tina Vilsb{\o}ll and Knop, {Filip Krag}",

year = "2014",

month = sep,

day = "29",

language = "Dansk",

volume = "176",

pages = "1874--1877",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "37",

}

TY - JOUR

T1 - Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt

AU - Rohde, Ulrich

AU - Gylvin, Silas

AU - Vilmann, Peter

AU - Friis, Steffen Ulrik

AU - Langholz, Ebbe

AU - Vilsbøll, Tina

AU - Knop, Filip Krag

PY - 2014/9/29

Y1 - 2014/9/29

N2 - Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.

AB - Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.

M3 - Tidsskriftartikel

C2 - 25294038

SN - 0041-5782

VL - 176

SP - 1874

EP - 1877

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 37

ER -

Behandling med duodenal-jejunal bypass-sleeve ved svær overvægt

Abstract

FN’s Verdensmål

Fingeraftryk

Citationsformater